Corpus Intelligence IC Memo — OTTAWA REGIONAL HOSPITAL & HEALTHCAR 2026-04-26 15:02 UTC
IC Memo — OTTAWA REGIONAL HOSPITAL & HEALTHCAR
Investment Committee Memorandum | IL | 97 beds | Grade C | EBITDA uplift $10.8M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

OTTAWA REGIONAL HOSPITAL & HEALTHCAR

CCN 140110 | LA SALLE, IL | 97 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

OTTAWA REGIONAL HOSPITAL & HEALTHCAR is a 97-bed suburban community hospital in LA SALLE, IL with $147.1M in net patient revenue and a 18.2% operating margin. The hospital serves a payer mix of 30.5% Medicare, 5.6% Medicaid, and 63.9% commercial.

Thesis: Turnaround. Our ML models identify $10.8M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 18.2% to 25.6% (+736bps).

Net Revenue HCRIS$147.1M
Current EBITDA COMPUTED$26.8M
Operating Margin COMPUTED18.2%
Occupancy HCRIS40.8%
Revenue / Bed COMPUTED$1.5M
Net-to-Gross HCRIS30.5%
Distress Probability ML50.4%

2. Market Context & Competitive Position

208
IL Hospitals
-5.3%
State Median Margin
81
Comparable Hospitals

IL has 208 Medicare-certified hospitals with a median operating margin of -5.3%. The target's margin of 18.2% places it above the state median. Among 81 size-comparable peers (48-194 beds), the median margin is -8.0%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (48-194), prioritizing same-state peers. 81 hospitals in the comp set.

HospitalStateBedsRevenueMargin
OTTAWA REGIONAL HOSPITAL & HEA (Target)IL97$147.1M18.2%
MIDWESTERN REGIONAL MEDICAL CEIL73$1.38B80.5%
NORTHWESTERN LAKE FOREST HOSPIIL124$494.3M-13.8%
SARAH BUSH LINCOLN HEALTH CENTIL100$448.6M-18.1%
DELNOR-COMMUNITY HOSPITALIL149$441.4M6.4%
GOOD SHEPHERD HOSPITALIL176$375.2M20.0%
JAVON BEA HOSPITALIL194$364.4M10.0%
SWEDISH COVENANT HEALTHIL173$363.5M-3.8%
MEMORIAL HOSPITAL OF CARBONDALIL175$357.2M14.6%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $10.8M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$3.1M+210bp18mo
Cost to Collect4.5%2.5%$2.9M+200bp12mo
Denial Rate Reduction12.0%6.5%$2.9M+198bp12mo
A/R Days Reduction5200.0%3800.0%$1.8M+122bp9mo
Clean Claim Rate88.0%96.0%$94K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$3.1M
Cost to Collect
$2.9M
Denial Rate Reduction
$2.9M
A/R Days Reduction
$1.8M
Clean Claim Rate
$94K
Total EBITDA Uplift$10.8M
Current EBITDA$26.8M
+ RCM Uplift+$10.8M
Pro Forma EBITDA$37.6M
Current Margin18.2%
Pro Forma Margin25.6%
WC Released (1x)$5.6M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$41.2M$284.9M6.92x47.2%
Base (11x exit)10.0x11.0x$41.2M$326.8M7.93x51.3%
Bull Case9.0x11.0x$37.1M$375.9M10.14x58.9%
Bull (12x exit)9.0x12.0x$37.1M$421.0M11.35x62.6%
Bear Case11.0x10.0x$45.3M$217.4M4.80x36.8%
Bear (11x exit)11.0x11.0x$45.3M$253.8M5.60x41.1%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighElevated distress probabilityModel estimates 50.4% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 81 hospitals with 48-194 beds
  • Same-state prioritization (n=82)
  • Comp margins: P25=-21.9% / P50=-8.0% / P75=4.1%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.